Immunotherapy Treatment Results – Memorial Hermann Hospital

Survival: ?
Toxicity Grade: 4
Treatments: Immunotherapy
Country: United States
City/State/Province: Houston, Texas
Hospital: Memorial Hermann Hospital
Journal: Link
Date: 12/2002


Patients: This Phase I study involved 29 patients with a variety of different cancers. One patient had mesothelioma.

Treatment: The treatment consisted of injections of recombinant human interleukin-12 (a protein).

Toxicity: Toxicities for all patients included grade 4 lymphopenia, and grade 3 or less nausea, vomiting, fatigue, fever, infection, and abdominal pain.

Results: Of 29 patients, two experienced complete response – the patient with mesothelioma is without progression at two years.

Correspondence: Ralph S. Freedman, MD

Get your free copy of
“Surviving Mesothelioma” Today!